Cleared Special

K092623 - F.A.S.T. SYSTEM SED AND CXD

K092623 is an FDA 510(k) clearance for F.A.S.T. SYSTEM SED AND CXD, manufactured by Genesis Medical Interventional, Inc.. The device is a Class 2 Cardiovascular device with product code QEW cleared through the Special 510(k) pathway after a 65-day FDA review.

K092623 · Genesis Medical Interventional, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2009
Decision
65d
Days
Class 2
Risk

K092623 is an FDA 510(k) clearance for the F.A.S.T. SYSTEM SED AND CXD. Classified as Peripheral Mechanical Thrombectomy With Aspiration (product code QEW), Class II - Special Controls.

Submitted by Genesis Medical Interventional, Inc. (Pleasanton, US). The FDA issued a Cleared decision on October 30, 2009 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5150 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K092623

510(k) Number K092623 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 26, 2009
Decision Date October 30, 2009
Days to Decision 65 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 125d · This submission: 65d
Pathway characteristics
Modification to existing cleared device.

QEW Device Classification - Class 2, Special Controls

Product Code QEW Peripheral Mechanical Thrombectomy With Aspiration
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5150
Definition To Mechanically Disrupt Thrombus And/or Debris Prior To Removal From The Peripheral Vasculature Through Aspiration.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - QEW Peripheral Mechanical Thrombectomy With Aspiration

All 144
Devices cleared under the same product code (QEW) and FDA review panel - the closest regulatory comparables to K092623.
ReVive PV (Peripheral Vasculature) Thrombectomy Device
K132281 · Codman & Shurtleff, Inc. · Aug 2013
ANGIOJET ULTRA POWER PULSE KIT
K130381 · Medrad, Inc. · Jul 2013
PENUMBRA EMBOLECTOMY ASPIRATION SYSTEM
K121917 · Penumbra, Inc. · Sep 2012
NEXGEN PERIPHERAL MECHANICAL RETRIEVAL DEVICE - 200CM, MODEL MRD-1000
K090932 · Nexgen Medical Systems, Inc. · Sep 2009
D-CLOT THROMBECTOMY CATHETER SYSTEM, MODEL: DC 4006
K083370 · Artegraft, Inc. · Dec 2008
LBI EMBOLECTOMY SYSTEM
K080901 · Lumen Biomedical, Inc. · Oct 2008
K092623 · F.A.S.T. SYSTEM SED AND CXD
Download PDF FDA Summary Genesis Medical Inter…